HCA Healthcare (NYSE:HCA) Given New $410.00 Price Target at Bank of America

Key Points

• Bank of America has increased its price target for HCA Healthcare from $375.00 to $410.00, maintaining a "neutral" rating, suggesting a potential upside of 3.00% from the previous close.
• HCA Healthcare reported earnings per share of $6.84 for the last quarter, surpassing estimates, with revenue of $18.61 billion.
• Current analysts' ratings indicate that one rates HCA as a Strong Buy, seven as Buy, and nine as Hold, reflecting a consensus target price of $403.17.

HCA Healthcare (NYSE:HCA - Get Free Report) had its target price upped by analysts at Bank of America from $375.00 to $410.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. Bank of America's price objective suggests a potential upside of 3.00% from the company's previous close.

Several other analysts have also commented on the stock. Morgan Stanley dropped their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Cantor Fitzgerald restated an "overweight" rating and set a $444.00 price target on shares of HCA Healthcare in a research report on Tuesday, August 26th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Finally, Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $403.17.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded down $15.33 during midday trading on Wednesday, reaching $398.07. The company's stock had a trading volume of 943,607 shares, compared to its average volume of 1,529,774. The firm has a market capitalization of $93.14 billion, a PE ratio of 16.75, a P/E/G ratio of 1.31 and a beta of 1.41. HCA Healthcare has a twelve month low of $289.98 and a twelve month high of $420.98. The stock has a fifty day moving average of $381.31 and a 200 day moving average of $361.47. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts expect that HCA Healthcare will post 24.98 EPS for the current fiscal year.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.30% of the company's stock.

Hedge Funds Weigh In On HCA Healthcare

A number of large investors have recently bought and sold shares of the company. Brighton Jones LLC purchased a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,021,000. LMR Partners LLP purchased a new position in shares of HCA Healthcare in the 4th quarter valued at about $326,000. OMERS ADMINISTRATION Corp increased its holdings in shares of HCA Healthcare by 3.3% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 13,067 shares of the company's stock valued at $3,922,000 after purchasing an additional 421 shares in the last quarter. Nuveen Asset Management LLC increased its holdings in shares of HCA Healthcare by 4.5% in the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock valued at $560,011,000 after purchasing an additional 81,105 shares in the last quarter. Finally, Numerai GP LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $1,026,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.